Combined use of MR contrast agents for evaluating liver disease

Magnetic Resonance Imaging Clinics of North America

Volumn 9, Issue 4, 2001, Pages 767-783

  Ward, J ^a   Robinson, P J ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM CHELATE; SUPERPARAMAGNETIC IRON OXIDE;

BILE DUCT CARCINOMA; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DRUG SAFETY; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; LOW BACK PAIN; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 0034760393     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1064-9689(21)00273-7     Document Type: Review

References (55)

1. Biliary carcinoma: A review of 109 cases
2. Improvements in survival by aggressive resections of hilar cholangiocarcinoma
3. Hepatic metastases: Basic principles and implications for radiologists
4. Liver metastases: Safety and efficacy of detection with superparamagnetic iron oxide MR imaging
5. Hepatic lesion detection at MR imaging: A comparative study with four sequences
6. The management of proximal biliary tract tumors
7. Incidence and diagnostic feature of macroregenerative nodules vs small hepatocellular carcinoma in cirrhotic livers
8. Macroregenerative nodules of the liver: A clinical pathologic study of 345 autopsy cases of chronic liver disease
9. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration
10. Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles
11. Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced flash MR imaging
12. Detection of liver metastases: Comparison of superparamagnetic iron oxide-enhanced MR imaging at 1.5T with dynamic CT, intraoperative US and percutaneous US
13. Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors
14. Liver metastases: Improved detection with dynamic gadolinium-enhanced MR imaging?
15. Focal liver lesions: Characterization with nonenhanced and dynamic contrast material-enhanced MR imaging
16. Hepatic lesions: Morphologic and functional characterization with multiphase breath-hold 3D gadolinium-enhanced MR angiography-initial results
17. MRI in focal hepatic disease: A comparison of Gd-DPTA and ferumoxides-enhanced MRI in over 900 patients
18. Adenocarcinoma of the hepatic duct at its bifurcation with the porta hepatis
19. Histological features and clinical course of large regenerative nodules: Evaluation of their precancerous potential
20. Dysplastic nodules in cirrhotic liver. Arterial phase enhancement at CT and MR imaginga case report
21. Carcinoma of the major extra-hepatic bile ducts exclusive of the papilla of Vater
22. Hypervascular malignant liver lesions: Comparison of various MR imaging pulse sequences and dynamic CT
23. Small hepatocellular carcinoma: Differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DPTA-enhanced MR imaging
24. Percutaneous ethanol injection therapy of adenomatous hyperplastic nodules in cirrhotic liver disease
25. Adenomatous hyperplastic nodules in the cirrhotic liver: A therapeutic approach
26. Abdominal MR imaging: Comparison of T2-weighted fast and conventional spin-echo, and contrast-enhanced fast multiplanar spoiled gradient recalled imaging
27. Hypervascular liver lesions: Differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging
28. Peripheral washout: A sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions
29. Benign and malignant nodules in cirrhotic livers: Distinction based on blood supply
30. Hepatic metastases and cavernous hemangiomas: Distinction with standard and triple dose Gadoteridol-enhanced MR imaging
31. SPIO-MR imaging versus double-phase spiral CT in detecting malignant lesions of the liver
32. Dynamic MR imaging and early-phase CT for detecting small intrahepatic metastases of hepatocellular carcinoma
33. Treatment of proximal biliary tract carcinoma: An overview of techniques and results
34. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging
35. MRI with superparamagnetic iron oxide: Efficacy in the detection and characterization of focal hepatic lesions
36. Hepatic malignancies: Usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging
37. Focal nodular hyperplasia of the liver on ferumoxides-enhanced MR imaging: Features on conventional spinecho, fast spin-echo and gradient-echo pulse sequences
38. Hepatic lesion detection and characterization: Value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging and spiral CT-ROC analysis
39. Hepatic MR imaging with ferumoxides: A multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions
40. Early hepatocellular carcinoma that develops within macroregenerative nodules: Growth rate depicted at serial MR imaging
41. Early stages of multistep hepatocarcinogenesis: Adenomatous hyperplasia and early hepatocellular carcinoma
42. MRI of liver: A comparison of CNR enhancement using high dose and low dose ferumoxide infusion in patients with colorectal liver metastases
43. Sequential use of ferumoxide particles and gadolinium chelate for the evaluation of focal liver lesions on MRI
44. Focal liver disease: Comparison of dynamic contrast-enhanced CT and T2 weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5T
45. Detection of hepatic metastases: Ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography
46. Detection of hepatocellular carcinomas arising in cirrhotic livers: Comparison of gadolinium-and ferumoxides-enhanced MR imaging
47. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions
48. Magnetic resonance imaging in the detection of focal liver lesions: Comparison of dynamic contrast-enhanced Turboflash and T2-weighted spin-echo images
49. Hepatic lesion detection after superparamagnetic iron oxide enhancement: Comparison of five T2-weighted sequences at 1.0T by using alternative-free response receiver operating characteristic analysis
50. Hepatocellular carcinoma in cirrhotic liver: Double-contrast MR imaging for diagnosis
51. Hepatic lesion detection: Comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis
52. Dual-contrast MR imaging of liver cancer in rats
53. Should hepatomas be treated with hepatic resection or transplantation?
54. Hepatocellular carcinoma in cirrhotic livers: Detection with unenhanced and iron oxide-enhanced MR imaging
55. Small hepatocellular carcinoma in patients with chronic liver damage: Prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver